France

France

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.8 (0.70 - 0.90) 2010 Survey/reported Ramiere, 2016
0.7 (0.50 - 0.90) 2004 Survey/reported Meffre C , 2010
0.02 (0.02 - 0.03) 2015 Modelled WHO
0.5 (0.40 - 0.70) 2016 Modelled Razavi-Shearer et al, 2018
0.7 (0.50 - 0.90) 2004 Survey/reported ECDC
0.26 (0.25 - 0.27) 2013 Modelled Schweitzer et al, 2015
1.38 (1.30 - 1.44) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1.55 (1.47 - 1.61) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.57 (1.49 - 1.64) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.58 (1.50 - 1.64) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.59 (1.49 - 1.66) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.6 (1.52 - 1.67) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.62 (1.54 - 1.69) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.64 (1.57 - 1.72) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.66 (1.59 - 1.74) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.68 (1.60 - 1.76) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.7 (1.61 - 1.77) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.71 (1.63 - 1.79) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.73 (1.64 - 1.80) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.75 (1.65 - 1.82) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.76 (1.66 - 1.84) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.77 (1.67 - 1.85) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.79 (1.69 - 1.87) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.8 (1.70 - 1.88) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.81 (1.71 - 1.89) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.83 (1.72 - 1.91) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.84 (1.74 - 1.92) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.85 (1.75 - 1.93) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.86 (1.77 - 1.94) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.87 (1.78 - 1.95) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.88 (1.78 - 1.96) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.89 (1.79 - 1.97) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.9 (1.80 - 1.98) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.91 (1.81 - 1.99) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.92 (1.82 - 2) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.93 (1.82 - 2.01) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.52 (1.43 - 1.59) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.01 (0.01 - 0.01) 2015 Modelled WHO
0.07 (0.05 - 0.09) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.12 (0.09 - 0.15) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.10 - 0.16) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.10 - 0.17) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.15 (0.11 - 0.19) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.17 (0.13 - 0.22) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.2 (0.15 - 0.25) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.23 (0.18 - 0.29) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.28 (0.22 - 0.34) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.32 (0.25 - 0.40) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.37 (0.28 - 0.46) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.41 (0.32 - 0.52) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.47 (0.37 - 0.58) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.52 (0.41 - 0.65) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.57 (0.44 - 0.72) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.46 - 0.77) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.49 - 0.81) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.66 (0.52 - 0.84) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.69 (0.54 - 0.87) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.7 (0.55 - 0.90) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.56 - 0.94) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.58 - 0.94) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.60 - 0.95) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.60 - 0.96) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.62 - 0.99) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.62 - 1.03) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.67 - 1.06) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.70 - 1.11) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.74 - 1.16) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.77 - 1.22) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.04 (0.80 - 1.31) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.15 (0.13 - 0.18) 2020 Modelled WHO
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
0.8 (0.60 - 0.70) 2011 Survey/reported Richaud-Eyraud E et al, 2015
People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
0.81 2011 Survey/reported EMCDDA
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
1.4 (0.70 - 2.40) 2009 Survey/reported Sauvage C et al , 2015
Prisoners
Download
Value (%) Year Type Source
0.6 (0.10 - 2.10) 2013 Survey/reported Corinne B et al, 2015.
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
353,000 (291,000 - 443,000) 2016 Modelled Razavi-Shearer et al, 2018
912,929 (861,308 - 951,234) 2019 Modelled IHME, GBD 2019 (accessed 2020)
945,541 (889,032 - 987,058) 2019 Modelled IHME, GBD 2019 (accessed 2022)
960,735 (909,127 - 1,000,070) 2018 Modelled IHME, GBD 2019 (accessed 2022)
969,284 (919,769 - 1,010,500) 2017 Modelled IHME, GBD 2019 (accessed 2022)
971,267 (923,168 - 1,011,730) 2016 Modelled IHME, GBD 2019 (accessed 2022)
973,280 (915,910 - 1,015,810) 2015 Modelled IHME, GBD 2019 (accessed 2022)
978,622 (926,631 - 1,020,980) 2014 Modelled IHME, GBD 2019 (accessed 2022)
986,264 (937,073 - 1,027,110) 2013 Modelled IHME, GBD 2019 (accessed 2022)
994,800 (946,684 - 1,036,190) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1,002,520 (954,710 - 1,044,200) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1,007,730 (957,724 - 1,050,900) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1,011,290 (962,153 - 1,054,300) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1,014,790 (963,676 - 1,057,520) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1,017,670 (963,919 - 1,060,180) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1,019,520 (962,951 - 1,064,480) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1,020,100 (961,515 - 1,066,540) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1,020,580 (963,665 - 1,066,150) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1,021,980 (965,132 - 1,068,970) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1,023,680 (966,311 - 1,068,640) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1,024,740 (965,908 - 1,067,580) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1,024,590 (967,237 - 1,069,210) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1,024,350 (966,972 - 1,067,700) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1,025,230 (972,190 - 1,068,150) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1,026,650 (975,131 - 1,069,630) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1,028,170 (978,267 - 1,071,300) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1,029,450 (977,061 - 1,073,320) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1,031,380 (979,107 - 1,074,270) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1,034,790 (983,453 - 1,078,690) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1,039,030 (987,043 - 1,083,050) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1,043,470 (990,848 - 1,089,320) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1,047,740 (990,134 - 1,095,300) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.64 (1.98 - 3.41) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3.5 (2.66 - 4.52) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3.5 (2.68 - 4.50) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3.52 (2.66 - 4.54) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3.54 (2.72 - 4.51) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3.58 (2.75 - 4.54) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3.62 (2.80 - 4.56) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3.73 (2.88 - 4.76) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3.68 (2.84 - 4.70) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3.67 (2.83 - 4.62) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3.72 (2.87 - 4.74) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3.65 (2.80 - 4.63) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3.6 (2.76 - 4.57) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3.54 (2.71 - 4.49) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3.46 (2.65 - 4.38) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3.22 (2.48 - 4.08) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3.16 (2.44 - 4.01) 2006 Modelled IHME, GBD 2019 (accessed 2022)
3.28 (2.53 - 4.16) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3.12 (2.41 - 3.94) 2007 Modelled IHME, GBD 2019 (accessed 2022)
3.1 (2.40 - 3.92) 2008 Modelled IHME, GBD 2019 (accessed 2022)
3.09 (2.39 - 3.90) 2009 Modelled IHME, GBD 2019 (accessed 2022)
3.06 (2.37 - 3.90) 2010 Modelled IHME, GBD 2019 (accessed 2022)
3.01 (2.34 - 3.83) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.97 (2.30 - 3.80) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.91 (2.26 - 3.73) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.84 (2.19 - 3.64) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.86 (2.20 - 3.67) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.76 (2.10 - 3.55) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.74 (2.08 - 3.52) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.64 (1.98 - 3.41) 2019 Modelled IHME, GBD 2019 (accessed 2022)
2.68 (2.03 - 3.47) 2018 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
3,845 2016 Modelled WHO
2,029 (1,544 - 2,624) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2,031 (1,536 - 2,625) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2,035 (1,556 - 2,619) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2,067 (1,589 - 2,632) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2,093 (1,608 - 2,655) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2,125 (1,643 - 2,677) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2,158 (1,665 - 2,719) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2,215 (1,710 - 2,821) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2,219 (1,711 - 2,827) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2,171 (1,677 - 2,778) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2,186 (1,677 - 2,775) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2,150 (1,646 - 2,724) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2,174 (1,667 - 2,756) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2,016 (1,559 - 2,557) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2,112 (1,622 - 2,679) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1,969 (1,521 - 2,500) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1,993 (1,534 - 2,527) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1,956 (1,513 - 2,474) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1,959 (1,518 - 2,476) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1,959 (1,516 - 2,476) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1,932 (1,499 - 2,458) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1,952 (1,512 - 2,488) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1,916 (1,482 - 2,446) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1,886 (1,460 - 2,413) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1,850 (1,428 - 2,367) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1,808 (1,377 - 2,331) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1,867 (1,435 - 2,401) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1,770 (1,341 - 2,288) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1,802 (1,371 - 2,316) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1,750 (1,314 - 2,259) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1,750 (1,314 - 2,259) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
11 (7 - 16) 1991 Modelled IHME, GBD 2019 (accessed 2022)
12 (8 - 17) 1992 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 15) 1990 Modelled IHME, GBD 2019 (accessed 2022)
12 (8 - 17) 1993 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 18) 1994 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 19) 1995 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 21) 1998 Modelled IHME, GBD 2019 (accessed 2022)
14 (9 - 20) 1996 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 20) 1997 Modelled IHME, GBD 2019 (accessed 2022)
15 (10 - 21) 1999 Modelled IHME, GBD 2019 (accessed 2022)
15 (10 - 21) 2000 Modelled IHME, GBD 2019 (accessed 2022)
15 (10 - 21) 2002 Modelled IHME, GBD 2019 (accessed 2022)
15 (10 - 21) 2001 Modelled IHME, GBD 2019 (accessed 2022)
15 (10 - 21) 2003 Modelled IHME, GBD 2019 (accessed 2022)
15 (10 - 22) 2004 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 22) 2005 Modelled IHME, GBD 2019 (accessed 2022)
16 (11 - 22) 2006 Modelled IHME, GBD 2019 (accessed 2022)
16 (11 - 22) 2007 Modelled IHME, GBD 2019 (accessed 2022)
16 (11 - 23) 2008 Modelled IHME, GBD 2019 (accessed 2022)
16 (11 - 23) 2009 Modelled IHME, GBD 2019 (accessed 2022)
16 (11 - 23) 2010 Modelled IHME, GBD 2019 (accessed 2022)
17 (12 - 23) 2011 Modelled IHME, GBD 2019 (accessed 2022)
17 (11 - 23) 2012 Modelled IHME, GBD 2019 (accessed 2022)
16 (11 - 23) 2013 Modelled IHME, GBD 2019 (accessed 2022)
16 (11 - 23) 2014 Modelled IHME, GBD 2019 (accessed 2022)
16 (11 - 23) 2015 Modelled IHME, GBD 2019 (accessed 2022)
16 (11 - 23) 2016 Modelled IHME, GBD 2019 (accessed 2022)
16 (10 - 22) 2017 Modelled IHME, GBD 2019 (accessed 2022)
15 (10 - 22) 2018 Modelled IHME, GBD 2019 (accessed 2022)
15 (10 - 22) 2019 Modelled IHME, GBD 2019 (accessed 2022)
12 (8 - 17) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
91 2019 Survey/reported WHO/UNICEF
91 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
109 2015 Survey/reported EMCDDA, 2019
150 (127 - 186) 2014 Survey/reported EMCDDA, 2017
109 2015 Survey/reported ECDC
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
85 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Many (31-60%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.3 (0.10 - 0.30) 2015 Modelled Blach et al, 2017
0.92 (0.76 - 1.13) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.75 - 1.12) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.74 - 1.11) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.74 - 1.11) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.9 (0.74 - 1.11) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.9 (0.74 - 1.11) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.74 - 1.12) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.75 - 1.12) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.75 - 1.12) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.75 - 1.12) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.74 - 1.09) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.86 (0.71 - 1.03) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.68 - 0.97) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.77 (0.64 - 0.92) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.62 - 0.90) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.62 - 0.88) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.73 (0.61 - 0.87) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.60 - 0.87) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.59 - 0.86) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.60 - 0.86) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.60 - 0.87) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.62 - 0.90) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.63 - 0.93) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.65 - 0.95) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.65 - 0.97) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.66 - 0.97) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.66 - 0.97) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.67 - 0.98) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.67 - 0.98) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.66 - 0.98) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.70 - 1.04) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.17 (0.08 - 0.20) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1 (0.90 - 1.20) 2010 Survey/reported Ramiere, 2016
0.84 (0.65 - 1.10) 2004 Survey/reported Meffre C et al, 2010
0.6 (0.40 - 1.10) 2014 Modelled Gower et al, 2014
0.84 2019 Modelled Jin et al. 2017
0.84 (0.80 - 1.10) 2004 Survey/reported ECDC
Showing out of
Show more
Men who have sex with men (MSM) Living with HIV
Download
Value (%) Year Type Source
5.6 (4 - 7.50) 2019 Modelled Jin et al. 2017
People who inject drugs (PWID)
Download
Value (%) Year Type Source
62.2 (59.40 - 64.90) 2011 Survey/reported Weill-Barillet L et al, 2016
People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
63.8 2011 Survey/reported EMCDDA
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
1 (0.50 - 1.90) 2009 Survey/reported Sauvage C et al , 2015
4.2 2019 Modelled Jin et al. 2017
Showing out of
Show more
Prisoners
Download
Value (%) Year Type Source
6.3 (6.10 - 6.50) 2016 Modelled ECDC
4.8 2013 Survey/reported ECDC
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
194,000 (93,000 - 222,000) 2015 Modelled Blach et al, 2017
441,233 (359,598 - 533,856) 1990 Modelled IHME, GBD 2019 (accessed 2022)
441,436 (363,321 - 531,785) 1991 Modelled IHME, GBD 2019 (accessed 2022)
440,946 (363,694 - 530,130) 1992 Modelled IHME, GBD 2019 (accessed 2022)
439,874 (363,545 - 531,073) 1993 Modelled IHME, GBD 2019 (accessed 2022)
438,345 (359,947 - 529,375) 1994 Modelled IHME, GBD 2019 (accessed 2022)
436,563 (356,717 - 529,856) 1995 Modelled IHME, GBD 2019 (accessed 2022)
431,499 (355,420 - 523,359) 1996 Modelled IHME, GBD 2019 (accessed 2022)
422,147 (350,045 - 510,433) 1997 Modelled IHME, GBD 2019 (accessed 2022)
411,831 (342,971 - 495,698) 1998 Modelled IHME, GBD 2019 (accessed 2022)
403,939 (337,162 - 487,375) 1999 Modelled IHME, GBD 2019 (accessed 2022)
402,174 (335,218 - 485,804) 2000 Modelled IHME, GBD 2019 (accessed 2022)
405,856 (335,964 - 488,991) 2001 Modelled IHME, GBD 2019 (accessed 2022)
411,383 (343,318 - 493,557) 2002 Modelled IHME, GBD 2019 (accessed 2022)
418,288 (349,047 - 498,618) 2003 Modelled IHME, GBD 2019 (accessed 2022)
426,277 (354,703 - 508,596) 2004 Modelled IHME, GBD 2019 (accessed 2022)
434,926 (361,867 - 521,016) 2005 Modelled IHME, GBD 2019 (accessed 2022)
451,194 (375,838 - 537,424) 2006 Modelled IHME, GBD 2019 (accessed 2022)
477,837 (397,992 - 570,398) 2007 Modelled IHME, GBD 2019 (accessed 2022)
507,674 (419,374 - 610,165) 2008 Modelled IHME, GBD 2019 (accessed 2022)
533,174 (438,684 - 647,224) 2009 Modelled IHME, GBD 2019 (accessed 2022)
546,635 (448,310 - 671,522) 2010 Modelled IHME, GBD 2019 (accessed 2022)
549,952 (452,267 - 673,434) 2011 Modelled IHME, GBD 2019 (accessed 2022)
551,060 (451,473 - 675,082) 2012 Modelled IHME, GBD 2019 (accessed 2022)
551,269 (450,962 - 677,535) 2013 Modelled IHME, GBD 2019 (accessed 2022)
551,958 (452,196 - 676,869) 2014 Modelled IHME, GBD 2019 (accessed 2022)
554,279 (452,051 - 682,128) 2015 Modelled IHME, GBD 2019 (accessed 2022)
557,484 (456,171 - 680,349) 2016 Modelled IHME, GBD 2019 (accessed 2022)
561,611 (459,268 - 686,343) 2017 Modelled IHME, GBD 2019 (accessed 2022)
567,214 (466,045 - 691,303) 2018 Modelled IHME, GBD 2019 (accessed 2022)
564,899 (464,402 - 691,765) 2019 Modelled IHME, GBD 2019 (accessed 2020)
573,278 (472,642 - 701,689) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
24,200 (11,500 - 27,600) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
8.09 (6.60 - 9.63) 2019 Modelled IHME, GBD 2019 (accessed 2020)
6.82 (5.50 - 8.38) 1991 Modelled IHME, GBD 2019 (accessed 2022)
6.92 (5.58 - 8.46) 1992 Modelled IHME, GBD 2019 (accessed 2022)
6.75 (5.42 - 8.34) 1990 Modelled IHME, GBD 2019 (accessed 2022)
7.11 (5.73 - 8.65) 1993 Modelled IHME, GBD 2019 (accessed 2022)
7.31 (5.88 - 8.87) 1994 Modelled IHME, GBD 2019 (accessed 2022)
7.48 (6.02 - 9.11) 1995 Modelled IHME, GBD 2019 (accessed 2022)
7.66 (6.18 - 9.36) 1996 Modelled IHME, GBD 2019 (accessed 2022)
7.92 (6.45 - 9.69) 1998 Modelled IHME, GBD 2019 (accessed 2022)
7.75 (6.28 - 9.49) 1997 Modelled IHME, GBD 2019 (accessed 2022)
7.97 (6.52 - 9.69) 1999 Modelled IHME, GBD 2019 (accessed 2022)
7.83 (6.40 - 9.50) 2000 Modelled IHME, GBD 2019 (accessed 2022)
7.82 (6.40 - 9.52) 2001 Modelled IHME, GBD 2019 (accessed 2022)
7.85 (6.44 - 9.54) 2002 Modelled IHME, GBD 2019 (accessed 2022)
7.86 (6.50 - 9.54) 2003 Modelled IHME, GBD 2019 (accessed 2022)
7.68 (6.28 - 9.31) 2004 Modelled IHME, GBD 2019 (accessed 2022)
7.72 (6.33 - 9.35) 2006 Modelled IHME, GBD 2019 (accessed 2022)
7.71 (6.29 - 9.34) 2005 Modelled IHME, GBD 2019 (accessed 2022)
7.79 (6.40 - 9.41) 2007 Modelled IHME, GBD 2019 (accessed 2022)
7.93 (6.47 - 9.58) 2008 Modelled IHME, GBD 2019 (accessed 2022)
8.03 (6.57 - 9.68) 2009 Modelled IHME, GBD 2019 (accessed 2022)
8.14 (6.65 - 9.77) 2011 Modelled IHME, GBD 2019 (accessed 2022)
8.11 (6.62 - 9.74) 2010 Modelled IHME, GBD 2019 (accessed 2022)
8.16 (6.68 - 9.77) 2012 Modelled IHME, GBD 2019 (accessed 2022)
8.12 (6.66 - 9.64) 2013 Modelled IHME, GBD 2019 (accessed 2022)
8.04 (6.51 - 9.53) 2014 Modelled IHME, GBD 2019 (accessed 2022)
8.17 (6.60 - 9.74) 2015 Modelled IHME, GBD 2019 (accessed 2022)
8.15 (6.63 - 9.73) 2017 Modelled IHME, GBD 2019 (accessed 2022)
8.06 (6.56 - 9.60) 2016 Modelled IHME, GBD 2019 (accessed 2022)
8.09 (6.60 - 9.63) 2019 Modelled IHME, GBD 2019 (accessed 2022)
8.11 (6.62 - 9.64) 2018 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
4,917 2016 Modelled WHO
5,356 (4,369 - 6,375) 2019 Modelled IHME, GBD 2019 (accessed 2022)
5,356 (4,369 - 6,375) 2019 Modelled IHME, GBD 2019 (accessed 2020)
5,353 (4,373 - 6,365) 2018 Modelled IHME, GBD 2019 (accessed 2022)
5,367 (4,363 - 6,406) 2017 Modelled IHME, GBD 2019 (accessed 2022)
5,287 (4,304 - 6,294) 2016 Modelled IHME, GBD 2019 (accessed 2022)
5,340 (4,315 - 6,367) 2015 Modelled IHME, GBD 2019 (accessed 2022)
5,228 (4,237 - 6,199) 2014 Modelled IHME, GBD 2019 (accessed 2022)
5,260 (4,314 - 6,244) 2013 Modelled IHME, GBD 2019 (accessed 2022)
5,261 (4,306 - 6,293) 2012 Modelled IHME, GBD 2019 (accessed 2022)
5,221 (4,261 - 6,265) 2011 Modelled IHME, GBD 2019 (accessed 2022)
5,175 (4,225 - 6,216) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5,096 (4,168 - 6,144) 2009 Modelled IHME, GBD 2019 (accessed 2022)
5,008 (4,087 - 6,051) 2008 Modelled IHME, GBD 2019 (accessed 2022)
4,890 (4,019 - 5,906) 2007 Modelled IHME, GBD 2019 (accessed 2022)
4,814 (3,950 - 5,833) 2006 Modelled IHME, GBD 2019 (accessed 2022)
4,777 (3,895 - 5,783) 2005 Modelled IHME, GBD 2019 (accessed 2022)
4,726 (3,865 - 5,731) 2004 Modelled IHME, GBD 2019 (accessed 2022)
4,804 (3,972 - 5,830) 2003 Modelled IHME, GBD 2019 (accessed 2022)
4,764 (3,910 - 5,790) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4,715 (3,861 - 5,741) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4,692 (3,835 - 5,696) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4,748 (3,883 - 5,773) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4,695 (3,828 - 5,749) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4,580 (3,711 - 5,604) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4,506 (3,636 - 5,506) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4,385 (3,528 - 5,343) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4,275 (3,440 - 5,189) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4,147 (3,340 - 5,045) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4,026 (3,246 - 4,923) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3,954 (3,188 - 4,857) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3,901 (3,132 - 4,820) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
33 (25 - 43) 1991 Modelled IHME, GBD 2019 (accessed 2022)
36 (27 - 45) 1992 Modelled IHME, GBD 2019 (accessed 2022)
31 (23 - 40) 1990 Modelled IHME, GBD 2019 (accessed 2022)
41 (31 - 52) 1994 Modelled IHME, GBD 2019 (accessed 2022)
38 (29 - 48) 1993 Modelled IHME, GBD 2019 (accessed 2022)
43 (32 - 54) 1995 Modelled IHME, GBD 2019 (accessed 2022)
45 (34 - 56) 1996 Modelled IHME, GBD 2019 (accessed 2022)
47 (35 - 59) 1997 Modelled IHME, GBD 2019 (accessed 2022)
48 (36 - 60) 1998 Modelled IHME, GBD 2019 (accessed 2022)
49 (37 - 62) 1999 Modelled IHME, GBD 2019 (accessed 2022)
49 (37 - 62) 2000 Modelled IHME, GBD 2019 (accessed 2022)
49 (38 - 62) 2001 Modelled IHME, GBD 2019 (accessed 2022)
51 (38 - 64) 2003 Modelled IHME, GBD 2019 (accessed 2022)
53 (41 - 66) 2004 Modelled IHME, GBD 2019 (accessed 2022)
50 (38 - 63) 2002 Modelled IHME, GBD 2019 (accessed 2022)
54 (41 - 67) 2005 Modelled IHME, GBD 2019 (accessed 2022)
55 (43 - 68) 2006 Modelled IHME, GBD 2019 (accessed 2022)
58 (46 - 72) 2008 Modelled IHME, GBD 2019 (accessed 2022)
57 (44 - 70) 2007 Modelled IHME, GBD 2019 (accessed 2022)
60 (46 - 73) 2009 Modelled IHME, GBD 2019 (accessed 2022)
61 (47 - 75) 2010 Modelled IHME, GBD 2019 (accessed 2022)
63 (49 - 77) 2012 Modelled IHME, GBD 2019 (accessed 2022)
63 (49 - 78) 2013 Modelled IHME, GBD 2019 (accessed 2022)
62 (49 - 76) 2011 Modelled IHME, GBD 2019 (accessed 2022)
63 (49 - 78) 2014 Modelled IHME, GBD 2019 (accessed 2022)
63 (49 - 78) 2015 Modelled IHME, GBD 2019 (accessed 2022)
62 (48 - 77) 2016 Modelled IHME, GBD 2019 (accessed 2022)
62 (47 - 77) 2017 Modelled IHME, GBD 2019 (accessed 2022)
60 (46 - 75) 2018 Modelled IHME, GBD 2019 (accessed 2022)
58 (44 - 73) 2019 Modelled IHME, GBD 2019 (accessed 2022)
45 (35 - 55) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of persons treated for HCV

National
Download
Value Year Type Source
17,325 2017 Survey/reported ECDC, 2019
17,325 2017 Survey/reported The European Centre for Disease Prevention and Control, 2019
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
109 2015 Survey/reported EMCDDA, 2019
150 (127 - 186) 2014 Survey/reported EMCDDA, 2017
109 2015 Survey/reported ECDC
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
85 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Many (31-60%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
1.52 (%)
2019
(1.43 - 1.59(%))
IHME, GBD 2019 (accessed 2022)
HCV (RNA/cAg+)
0.92 (%)
2019
(0.76 - 1.13(%))
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

HBV (HBsAg+)
0.8 (%)
2010
(0.7 - 0.9(%))
Ramiere, 2016
HCV (anti-HCV)
1 (%)
2010
(0.9 - 1.2(%))
Ramiere, 2016

Hepatitis related deaths (national)

Modelled

HBV
1,750
2019
(1,314 - 2,259)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
5,356
2019
(4,369 - 6,375)
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.15 (%)
2020, latest modelled
(0.13 - 0.18(%))
WHO

Prevalence PWID

HCV
62.20 (%)
2011, survey/surveillance
(59.40 - 64.90(%))
Weill-Barillet L et al, 2016

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
109
2015
EMCDDA, 2019
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Latest news

View all

News

Resources

Programs

Partners